Pharmacogenetic approaches to rheumatoid arthritis.
- Published in:
- Pharmacogenomics Journal, 2004, v. 4, n. 6, p. 350, doi. 10.1038/sj.tpj.6500263
- By:
- Publication type:
- Article
Works matching IS 1470269X AND DT 2004 AND VI 4 AND IP 6
Results: 12
1
2
Chronic lithium treatment of B lymphoblasts from bipolar disorder patients reduces transient receptor potential channel 3 levels.
- Published in:
- Pharmacogenomics Journal, 2004, v. 4, n. 6, p. 365, doi. 10.1038/sj.tpj.6500266
- By:
- Publication type:
- Article
3
Identification of a pharmacogenetic effect by linkage disequilibrium mapping.
- Published in:
- Pharmacogenomics Journal, 2004, v. 4, n. 6, p. 374, doi. 10.1038/sj.tpj.6500268
- By:
- Publication type:
- Article
4
Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment.
- Published in:
- Pharmacogenomics Journal, 2004, v. 4, n. 6, p. 379, doi. 10.1038/sj.tpj.6500274
- By:
- Publication type:
- Article
5
Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors.
- Published in:
- Pharmacogenomics Journal, 2004, v. 4, n. 6, p. 388, doi. 10.1038/sj.tpj.6500275
- By:
- Publication type:
- Article
6
Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variant.
- Published in:
- Pharmacogenomics Journal, 2004, v. 4, n. 6, p. 394, doi. 10.1038/sj.tpj.6500276
- By:
- Publication type:
- Article
7
Pharmacogenetics Research Network and Knowledge Base Fourth Scientific Meeting.
- Published in:
- Pharmacogenomics Journal, 2004, v. 4, n. 6, p. 359, doi. 10.1038/sj.tpj.6500277
- By:
- Publication type:
- Article
8
Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards.
- Published in:
- Pharmacogenomics Journal, 2004, v. 4, n. 6, p. 403, doi. 10.1038/sj.tpj.6500278
- By:
- Publication type:
- Article
9
Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs.
- Published in:
- Pharmacogenomics Journal, 2004, v. 4, n. 6, p. 354, doi. 10.1038/sj.tpj.6500284
- By:
- Publication type:
- Article
10
Importance of patient selection when determining the significance of the CYP3A5 polymorphism in clinical trials.
- Published in:
- Pharmacogenomics Journal, 2004, v. 4, n. 6, p. 362, doi. 10.1038/sj.tpj.6500286
- By:
- Publication type:
- Article
11
Pharmacogenomics in admixed populations: the Brazilian pharmacogenetics/pharmacogenomics network-REFARGEN.
- Published in:
- 2004
- By:
- Publication type:
- Editorial
12
In This Issue.
- Published in:
- 2004
- Publication type:
- Abstract